Doctors warn against stopping 3 meds after carcinogenic classification

The International Agency for Research on Cancer (IARC), part of the World Health Organization, has classified three common medications—hydrochlorothiazide, furoconazole, and tacrolimus—as possibly carcinogenic to humans. This has raised concerns among patients; however, physicians emphasize that this classification does not necessarily mean that these medications should be stopped abruptly. Hydrochlorothiazide is used to treat high blood pressure, furoconazole for severe fungal infections, and tacrolimus to prevent organ rejection after transplantation. All three are associated with an increased risk of certain cancers, particularly skin cancers and lymphomas, but the actual danger depends on factors such as dosage and duration of use. Doctors advise against stopping these drugs suddenly without medical consultation to avoid serious complications. They also affirm that the benefits of these treatments—which have saved millions of lives—outweigh the potential risks, and that maintaining a careful balance between risks and benefits, based on an individual medical assessment, remains essential.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article